← Study Library
Animal · 2021
Preclinicalcounts toward this tierBetaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone
Yajun W, et al. · Frontiers in Pharmacology
Preclinicalcounts toward this tier
Betaine reduced cartilage proteoglycan loss, lowered OARSI histology scores, decreased MMP-13/collagen-X-positive cells and normalised subchondral bone remodelling and aberrant angiogenesis, apparently via ROS/MAPK-dependent inhibition of osteoclastogenesis.
- Population
- Mice with surgically induced (ACLT) knee OA; osteoclast cultures
- Intervention
- Betaine 2% w/v in drinking water from the day after ACLT surgery, to 14, 30 or 60 days
- Comparator
- Untreated ACLT mice
- Limitations
- Mouse surgical-OA model; the methods state the dose but not the group sizes; no human data. Funded by Chinese national and Shanghai grants; no conflicts declared.
Cited by
1 entry references this study
- TMG (Betaine)PRECL.
Supplements → Vitamins & cofactors · key study
Evidence for that entry
Preclinical